IL18 and metabolic syndrome: In corroboration with this line of argument, Troseid et al. suggested that hyperglycemia and inflammation had a mutually potentiating effect in cardiovascular risk prediction and they also showed that IL‐18 was a strong independent predictor of cardiovascular events in metabolic syndrome patients, especially in those with elevated fasting glucose levels 31.